Loading...

Ajooni Biotech Rights Issue 2022 Latest News Today

Ajooni Biotech Rights Issue 2022 Detail
Issue Open Dec 7, 2022
Issue Close Dec 19, 2022
Issue Size (Shares) 4.84 Crores
Issue Size (Amount) ₹29.02 Crores
Issue Price ₹6 per Share
Listing At NSE
  1. Ajooni Biotech Ltd (AJOO)

    Jan 6, 2023 2:26:00 PM

    A summary for the Ajooni Biotech Ltd share. Signals range from Strong Buy, Buy, Neutral, Sell to Strong Sell. It also offers detailed technical analysis based on the buy/sell signals of moving ...

    Publish by : Investing
  2. The biggest private biotech investments in December 2022

    Jan 9, 2023 3:30:00 AM

    The companies Apogee Therapeutics, Pulmocide and Qitan Technology bagged the biggest biotech investments in December 2022. Around the world, immunology and manufacturing players attracted the biggest ...

    Publish by : labiotech
  3. Investing in Biotech Stocks in 2023

    Jan 20, 2023 3:22:00 PM

    The U.S. Food and Drug Administration (FDA) identified two manufacturing deficiencies in the company’s regulatory filing, but Axsome believes the issues ... biotech stock to consider buying in 2022.

    Publish by : The Motley Fool
  4. Rights group: Litany of crises in 2022 but also good signs

    Jan 11, 2023 3:30:00 AM

    A “litany of human rights crises” emerged in 2022, but the year also presented ... If you don't see it, please check your junk folder. The next issue of NP Posted will soon be in your inbox.

    Publish by : National Post
  5. 2022 turns out to be another unspectacular year for pharma and biotech M&A

    Jan 11, 2023 3:30:00 AM

    During the whole of 2022, merger and acquisition (M&A) activity in the pharma and biotech sector showed a slight improvement on 2021, when it fell to a decade low of just 92 deals, with a total number ...

    Publish by : The Pharma Letter
  6. Acticor Biotech Postpones Release of Its 2022 Half-Year Financial Results

    Jan 27, 2023 3:31:00 AM

    In May 2022, Acticor Biotech presented positive results from its Phase 1b/2a study, ACTIMIS, at the ESOC, confirming the safety profile and showing a reduction in mortality and intracerebral ...

    Publish by : Finanznachrichten
  7. Routes magazine: Issue 4, 2022

    Jan 4, 2023 10:05:00 PM

    Our third daily magazine for Routes World 2022 includes full coverage of the Routes Awards, an interview with Allegiant Air's president and CEO John Redmond, and a look at Greenland game-changing ...

    Publish by : Routesonline
  8. Industronics rights issue undersubscribed

    Jan 17, 2023 4:18:00 AM

    KUALA LUMPUR: Industronics Bhd ’s proposed rights issue to raise funds was undersubscribed by 69.14%. In a filing with Bursa Malaysia, the company said the minimum subscription level for the ...

    Publish by : The Star
  9. Known Medicine Announces BioTech Breakthrough Award for "Best Use of Artificial Intelligence in BioTech 2022"

    Jan 19, 2023 7:36:00 PM

    has been awarded the prestigious "Best Use of Artificial Intelligence in BioTech 2022" by BioTech Breakthrough Awards. Known Medicine is building the world's largest purpose-built 3-dimensional ...

    Publish by : Le Lézard
  10. Ajooni Biotech Ltd (AJOO)

    Jan 12, 2023 1:30:00 PM

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

    Publish by : Investing

Read Ajooni Biotech Rights Issue 2022 current news. Find Ajooni Biotech Rights Issue 2022 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Ajooni Biotech Limited Rights Issue grey market premium and Ajooni Biotech Rights Issue 2022 expected listing price.


Comments

Add a public comment...